Effect of Pulmonary Rehabilitation on Fear of Falling in COPD Patients (PARACHUTE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03793452 |
|
Recruitment Status :
Completed
First Posted : January 4, 2019
Last Update Posted : July 16, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Copd |
| Study Type : | Observational |
| Actual Enrollment : | 80 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Effect of Pulmonary Rehabilitation on Fear of Falling in COPD Patients |
| Actual Study Start Date : | January 18, 2019 |
| Actual Primary Completion Date : | December 18, 2019 |
| Actual Study Completion Date : | December 18, 2019 |
- measure of fear of falling after a pulmonary rehabilitation [ Time Frame: 4 weeks ]measure of fear of falling (FES-I) before and after a pulmonary rehabilitation program
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- COPD patients
Exclusion Criteria:
- post surgical rehabilitation
- neurologic or orthopedic disorders limiting walking
- imbalance disorders
- inability to answer to the questionnaire
- refusal to participate.
- inability to perform the pulmonary rehabilitation program.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03793452
| France | |
| CH Pays de Morlaix | |
| Morlaix, France, 29672 | |
| Principal Investigator: | Marc Beaumont, PhD | CH DES PAYS DE MORLAIX |
| Responsible Party: | University Hospital, Brest |
| ClinicalTrials.gov Identifier: | NCT03793452 |
| Other Study ID Numbers: |
PARACHUTE (29BRC18.0246) |
| First Posted: | January 4, 2019 Key Record Dates |
| Last Update Posted: | July 16, 2020 |
| Last Verified: | July 2020 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
COPD, pulmonary rehabilitation, fear of falling, evaluation |

